Ibrutinib Impurity 22 CAS CATO-C4X-106422

Purity >95%In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-106422
Molecular FormulaC36H30O2P2
Molecular Weight556.57 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Ibrutinib Impurity 22 CAS CATO-C4X-106422 chemical structure

Description

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

Ibrutinib Impurity 22 (CAS CATO-C4X-106422) is a certified pharmaceutical impurity reference standard with the molecular formula C36H30O2P2 and a molecular weight of 556.57 g/mol.

Structurally, Ibrutinib Impurity 22 (C36H30O2P2) contains organophosphorus functionality, a carboxylic acid group, a hydroxyl group, an ether linkage, a polycyclic aromatic system. The molecule exhibits a degree of unsaturation (DBE) of 22.0, corresponding to approximately 22 ring(s) or double-bond equivalent(s). With a molecular weight of 556.57 g/mol, it falls into the moderately-high-molecular-weight range. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

As a certified reference material (CRM), Ibrutinib Impurity 22 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Molecular FormulaC36H30O2P2
Molecular Weight556.57 g/mol
AppearancePale yellow to yellow crystalline powder
Purity>95%
StorageStore at room temperature, protect from light
Solubility (reference)Soluble in chloroform, dichloromethane, ethyl acetate, DMSO
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)22.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present

Related Ibrutinib Standards

Recommended Standards

Why CATO?